LifeVantage (NASDAQ:LFVN) Shares Cross Above 200 Day Moving Average of $6.64

LifeVantage Co. (NASDAQ:LFVN) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.64 and traded as high as $8.57. LifeVantage shares last traded at $8.35, with a volume of 77,470 shares traded.

LifeVantage Price Performance

The business’s 50-day moving average is $6.97 and its two-hundred day moving average is $6.64. The firm has a market cap of $106.05 million, a P/E ratio of 29.82 and a beta of 0.81.

LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.21 earnings per share for the quarter. LifeVantage had a return on equity of 27.02% and a net margin of 1.75%. The company had revenue of $48.25 million during the quarter.

Hedge Funds Weigh In On LifeVantage

Several hedge funds and other institutional investors have recently made changes to their positions in LFVN. Hantz Financial Services Inc. bought a new position in shares of LifeVantage in the 2nd quarter valued at about $91,000. Hillsdale Investment Management Inc. bought a new stake in LifeVantage in the first quarter valued at approximately $76,000. Acadian Asset Management LLC lifted its position in shares of LifeVantage by 2.8% in the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after buying an additional 6,121 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of LifeVantage by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after acquiring an additional 12,809 shares during the period. Finally, Empowered Funds LLC increased its holdings in shares of LifeVantage by 8.1% during the 1st quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after acquiring an additional 5,742 shares during the last quarter. 35.32% of the stock is owned by institutional investors.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.